Plain-English translation of NCT05808933 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are investigating whether a specialized form of MRI imaging called Magnetic Resonance Fingerprinting can help doctors better understand early-stage cervical cancer before surgery. This imaging technique may help predict whether cancer cells have invaded the blood vessels and lymph nodes around the tumor. The goal is to give doctors better information to plan the safest and most effective surgery for each patient.
Currently, doctors don't have a reliable way to know before surgery whether early cervical cancers have spread to nearby blood vessels and lymph nodes. This new imaging technique could fill that gap and help guide surgical planning and treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo a specialized MRI scan as part of your preoperative evaluation before surgery. This scan uses advanced imaging technology to create detailed pictures of your tumor. The study is observational, meaning researchers will follow your case and compare the MRI findings with surgical findings to learn whether this imaging technique can predict cancer spread.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Italy
Enrollment target
~150 participants
Started
June 2022
Primary completion
December 2027
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in April 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Benedetta B Gui, MD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.